Tech

Anagenex, which combines AI and large-scale proprietary data sets for drug discovery, has raised $30 million in Series A funding led by Catalio Capital Management (Arundhati Parmar/MedCity News)




Arundhati Parmar / News about MedCity:

Anagenex, which combines AI and large-scale proprietary data sets for drug discovery, has raised $30 million Series A led by Catalio Capital ManagementAnagenex CEO believes the company’s AI engine trained on billions of data points and repeated testing will blow away other AI drug discovery startups.





Source link

news7h

News7h: Update the world's latest breaking news online of the day, breaking news, politics, society today, international mainstream news .Updated news 24/7: Entertainment, Sports...at the World everyday world. Hot news, images, video clips that are updated quickly and reliably

Related Articles

Back to top button